In Brief: Organon Remeron
Executive Summary
Organon Remeron: Designated "approvable" at FDA Jan. 26. The alpha2-receptor antagonist was recommended for approval for the treatment of depression by FDA's Psychopharmacologic Drugs Advisory Committee at an Oct. 16 meeting ("The Pink Sheet" Oct. 23, 1995, p. 16). Remeron (mirtazapine), a tetracyclic compound, is the first drug in its class to reach the approvable stage in the U.S...